Oral tolerance in experimental autoimmune neuritis (EAN) of the Lewis rat II. Adjuvant effects and bystander suppression in P2 peptide-induced EAN

Journal of Neuroimmunology

Volumn 116, Issue 1, 2001, Pages 21-28

  Jung, Stefan ^a,b   Gaupp, Stefanie ^a   Hartung, Hans Peter ^a   Toyka, Klaus V ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Antigen therapy; EAN; Guillain Barr syndrome; Immunomodulation; Tolerance

Indexed keywords

CHOLERA TOXIN; IMMUNOLOGICAL ADJUVANT; KEYHOLE LIMPET HEMOCYANIN; MYELIN; PROTEIN; PROTEIN P2; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DEMYELINATING NEUROPATHY; DRUG EFFECT; DRUG MECHANISM; FEMALE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INDUCTION; RAT; RAT STRAIN; SPLEEN CELL;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANIMALS; ANTIFUNGAL AGENTS; AUTOIMMUNE DISEASES; CELL DIVISION; CHOLERA TOXIN; FEMALE; IMMUNE TOLERANCE; IMMUNIZATION; MYELIN PROTEINS; NEURITIS; RATS; SPLEEN;

EID: 0035341332     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(01)00276-4     Document Type: Article

References (34)

1. Antigen-driven tissue-specific suppression following oral tolerance: Orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse
2. Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta 1 and beta 2 chain expression
3. Cholera toxin enhances alloantigen presentation by cultured intestinal epithelial cells
4. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis
5. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen
6. Oral tolerance: Mechanisms and therapeutic applications
7. Mechanisms of oral tolerance
8. Modulation of experimental autoimmune neuritis in Lewis rats by oral application of myelin antigens
9. Experimental allergic neuritis (EAN) as a model for the immune-mediated demyelinating neuropathies
10. Immunopathogenesis and treatment of the Guillain-Barré syndrome - Part I
11. Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide
12. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain
13. Cholera toxin and cholera toxin B subunit induce IgA switching through the action of TGF-beta 1
14. Cholera toxin B subunit binding to an antigen-presenting cell directly co-stimulates cytokine production from a T cell clone
15. The adjuvant action of cholera toxin is associated with an increased intestinal permeability for luminal antigens
16. Enhancing effect of cholera toxin on interleukin-6 secretion by IEC-6 intestinal epithelial cells: Mode of action and augmenting effect of inflammatory cytokines
17. Selective tolerization of Th1-like cells after nasal administration of a cholera toxoid-LACK conjugate
18. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: Influence of MHC binding affinity
19. Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: Role of cAMP in T cell proliferation
20. Oral administration of acetylcholine receptor: Effects on experimental myasthenia gravis
21. Modulation of oral tolerance to ovalbumin by cholera toxin and its B subunit
22. Bystander suppression in experimental autoimmune encephalomyelitis: Where and how does it occur?
23. Cholera toxin B subunit: An efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance
24. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit
25. The function of TGF-beta-mediated innocent bystander suppression associated with physiological self-tolerance in vivo
26. Eighty-three years of the Guillain-Barré syndrome: Clinical and immunopathogenic aspects, current and future treatments
27. Effects of oral administration of type II collagen on rheumatoid arthritis
28. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis
29. Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye
30. Immune modulation by the cholera-like enterotoxins: From adjuvant to therapeutic
31. An α-chain TCR CDR3 peptide can enhance EAE induced by myelin basic protein or proteolipid protein
32. Suppression of antigen-induced arthritis in Lewis rats by oral administration of type II collagen
33. The three-dimensional crystal structure of cholera toxin
34. Prevention of experimental autoimmune neuritis by nasal administration of P2 protein peptide 57-81